Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9416768Aexternal-prioritypatent/GB9416768D0/en
Priority claimed from GB9416767Aexternal-prioritypatent/GB9416767D0/en
Application filed by Nycomed Imaging AsfiledCriticalNycomed Imaging As
Priority claimed from PCT/GB1995/001969external-prioritypatent/WO1996005867A2/en
Publication of FI970667A7publicationCriticalpatent/FI970667A7/en
Publication of FI970667A0publicationCriticalpatent/FI970667A0/en
Publication of FI970667LpublicationCriticalpatent/FI970667L/en
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Medicinal Preparation
(AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Compositions Of Macromolecular Compounds
(AREA)
Abstract
There is provided a contrast medium composition comprising a physiologically tolerable manganese compound, an uptake promoter and a physiologically tolerable carrier or excipient, having a manganese concentration of at least 0.3mM or being in a dosage unit form containing at least 300 .mu.mol manganese, wherein the uptake promoter comprises a physiologically tolerable reducing compound containing an .alpha.-hydroxy ketone group, a physiologically tolerable acid containing .alpha.- and/or .beta.-hydroxy or amino groups, or a salt thereof, and/or vitamin D. Such compositions are particularly suitable for imaging of the liver.
Cross-linkable monomers and compositions, as well as process for the preparation of cross-linked polymerates, cross-linked metathesis polymerisates, coated carriers and substrates
Tricyclic Compounds Having Activity Specific for Integring, Particularly , avB3 Integrins, Method for Preparation the Same as Drugs and Pharmaceutical Composition Containing Same